Prior vaccination with the autologous Tumor Lysate Particle Loaded Dendritic Cell (TLPLDC) Vaccine may impact clinical outcomes in melanoma patients treated with systemic therapies and re-vaccination-MedSci.cn

Prior vaccination with the autologous Tumor Lysate Particle Loaded Dendritic Cell (TLPLDC) Vaccine may impact clinical outcomes in melanoma patients treated with systemic therapies and re-vaccination

Hickerson, AT; Clifton, GT; Brown, TA; Cindass, JL; Myers, JW; Vreeland, TJ; Hale, DF; Peace, KM; Jackson, DO; Herbert, G; Yu, XZ; Wagner, TE; Peoples, GE

CANCER RESEARCH, 2019; 79 (13):

科室
- - 订阅+
  - 更多科室
工具
服务